Eli Lilly hiked its outlook as sales soared for its popular weight-loss drugs Zepbound and Mounjaro.  The company also ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

Gallup’s latest health index links the rapid rise of semaglutide and similar injectables to measurable population-level weight loss.

Liraglutide compared with placebo (a sham medication) likely increases the number of people who lose at least 5% of their body weight, but its impact on unwanted effects, quality of life, and major ...